Cronos Group Inc. (CRON)
Medicinal Chemicals & Botanical Products
Latest Price
$2.83
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
2.83
P/B Ratio
1.00
Valuation metrics
adjust assumptions →Base FCF: $3M (median of recent 5yr)
Growth: -15%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$2.22
22% downside
Institutional Ownership
10.2% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 7.62M | $19.0M | 2.02% | +758.8K | 2026-03-31 |
| Pillsbury Lake Capital LLC | 4.22M | $10.0M | 1.12% | +2.38M | 2026-03-31 |
| Tidal Investments LLC | 4.03M | $10.0M | 1.07% | -116.1K | 2026-03-31 |
| DIMENSIONAL FUND ADVISORS LP | 2.68M | $6.0M | 0.71% | +172.8K | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 2.01M | $5.0M | 0.53% | +164.5K | 2026-03-31 |
| CIBC WORLD MARKET INC. | 1.35M | $3.0M | 0.36% | -- | 2026-03-31 |
| JANE STREET GROUP, LLC | 1.04M | $2.0M | 0.28% | -485.6K | 2026-03-31 |
| MMCAP International Inc. SPC | 999.5K | $2.0M | 0.27% | -1.76M | 2026-03-31 |
| Quinn Opportunity Partners LLC | 969.0K | $2.0M | 0.26% | -- | 2026-03-31 |
| CDC Financial, Inc. | 926.8K | $2.0M | 0.25% | -20.0K | 2026-03-31 |